CASR and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, in CML CaSR-deficiency on LIC resulted in a trend towards increased leukocytes (Supplementary Fig. 9a), no differences in the percentage of BCR-ABL1+ CD11b+ myeloid cells in PB (Supplementary Fig. 9b), but the significant shortening of survival of recipient mice (P = 0.049, Fig. 3b).